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Under a context of survival lifetime analysis, we introduce in this paper
Bayesian and maximum likelihood approaches for the bivariate Basu-Dhar
geometric model in the presence of covariates and a cure fraction. This dis-
tribution is useful to model bivariate discrete lifetime data. In the Bayesian
estimation, posterior summaries of interest were obtained using standard
Markov Chain Monte Carlo methods in the OpenBUGS software. Maximum
likelihood estimates for the parameters of interest were computed using the
“maxLik” package of the R software. Illustrations of the proposed approaches
are given for two real data sets.
keywords: Basu-Dhar distribution, cure fraction, discrete distributions,
MCMC methods, lifetime data.
1. Introduction
Discrete-time survival analysis has been applied in many contexts including educational
research (Singer and Willett, 1993), clinical psychology (Herzog et al., 1997) and medical
studies (Scheike and Jensen, 1997). These analyses treat time to event data not as a
continuous variable. Instead, it is considered discrete values in which the event of interest
could occur. In this way, let T be a discrete random variable that takes positive integer
values k, k = 1, 2, 3, ..., with probabilities P (T = k). The survival function at time k is
thus defined as
S (k) = P (T ≥ k) =
∞∑
j=k
P (T = j).
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The discrete Weibull distribution (Nakagawa and Osaki, 1975) is widely employed in
modeling and analyzing lifetime data, but a large number of new discrete distributions
has been proposed by several researchers (Almalki and Nadarajah, 2014; Dewan et al.,
2016; Kulasekera and Tonkyn, 1992; Roy, 2004). In a special case, we may suppose that
the data consists of two lifetimes T1 and T2 associated with each unit. The assumption
of independence between these random variables can be unrealistic since the value of one
variable can influence value of the other variable. In this context, a considerable num-
ber of parametric distributions assuming continuous bivariate lifetimes is found in the
literature (Block and Basu, 1974; Freund, 1961; Hawkes, 1972; Sarkar, 1987), including
the presence of censoring. Considering discrete lifetimes in place of continuous lifetime
observations, Basu and Dhar (1995) derived the bivariate geometric distribution as an
analogue to the bivariate distribution introduced by Marshall and Olkin (1967). Achcar
et al. (2016) considered the parameter estimation of the Basu-Dhar distribution using
Bayesian and maximum-likelihood methods in the presence of covariates and censored
data. A discussion about computational issues related to the use of the Basu-Dhar dis-
tribution in applications with complete and censored datasets is provided by Oliveira
and Achcar (2018).
In the present article we consider the bivariate Basu-Dhar geometric model for sur-
vival data in presence of a cure fraction. The cure fraction models are useful to model
lifetime data with long-term survivors (Boag, 1949), where it is believed that a propor-
tion of individuals will not experience the event of interest (Lambert et al., 2007). The
presence of these individuals in a data set is suggested by a Kaplan-Meier plot of the
survival function showing a long and stable plateau with heavy censoring at the extreme
right of the plot (Martinez et al., 2013). We implemented the statistical model under
a Bayesian framework with parameter estimation based on Markov Chain Monte Carlo
(MCMC) methods. In a similar context, Davarzani et al. (2015) introduced a Bayesian
analysis for the bivariate geometric distribution proposed by Arnold (1975) in the pres-
ence of covariates, censored data and cure fraction using MCMC methods. Although the
distribution introduced by Arnold (1975) is also derived from the bivariate distribution
by Marshall and Olkin, its joint mass probability has a different formulation from the
Basu-Dhar geometric distribution.
2. Methods
2.1. The Basu-Dhar bivariate geometric distribution
Let T1 and T2 be two random variables that represent the time to events of interest.
The joint survival function of the Basu-Dhar bivariate geometric (BDBG) distribution
is given by
S(t1, t2) = P (T1 > t1, T2 > t2) = p
t1
1 p
t2
2 p
max(t1,t2)
3 ,
where t1 ≥ 1 and t2 ≥ 1 are respectively discrete observations of T1 and T2, 0 < p1 < 1,
0 < p2 < 1 and 0 < p3 ≤ 1. Achcar et al. (2016) described that this function satisfies
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the loss of memory property without any additional parameter restrictions, or say, for
any integer δ > 0,
P (T1 > s1 + δ, T2 > s2 + δ|T1 > s1, T2 > s2) = P (T1 > δ, T2 > δ) = (p1p2p3)δ .
The respective bivariate mass function is given by
P (T1 = t1, T2 = t2) =

pt1−11 (1− p1) (p2p3)t2−1 (1− p2p3) for T1 < T2
pt2−12 (1− p2) (p1p3)t1−1 (1− p1p3) for T1 > T2
(p1p2p3)
t1−1 (1− p1p3 − p2p3 + p1p2p3) for T1 = T2
.
The marginal distributions for Tk are given by
P (Tk = tk) = (1− pkp3) (pkp3)tk−1 , k = 1, 2, (1)
and the respective means are given by
E (Tk) =
∞∑
j=1
[j × P (Tk = j)] = 1
1− pkp3 , k = 1, 2. (2)
We can observe that
P (T1 = t1, T2 > t2) =
{
pt1−11 (1− p1) (p2p3)t2 for T1 ≤ T2
pt22 (p1p3)
t1−1 (1− p1p3) for T1 > T2
,
and
P (T1 > t1, T2 = t2) =
{
pt11 (p2p3)
t2−1 (1− p2p3) for T1 < T2
pt2−12 (1− p2) (p1p3)t1 for T1 ≥ T2
.
Since
P (Tk < tk) = (1− pkp3)
tk−1∑
j=1
(pkp3)
j−1 = 1− (pkp3)tk−1 , k = 1, 2,
we obtain the marginal survival function for the lifetime k given by
Sk(tk) = 1− P (Tk < tk) = (pkp3)tk−1 , k = 1, 2, (3)
and, from (1), the respective marginal hazard function is given by
hk(tk) =
P (Tk = tk)
Sk(t)
=
(1− pkp3) (pkp3)tk−1
(pkp3)
tk−1 = (1− pkp3) , k = 1, 2.
Thus, the BDBG distribution is characterized by a constant hazard function.
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2.2. Presence of right-censored data
Let us suppose that either T1 and T2 can be censored and that censoring is independent
of the time to the events considered by the study researchers. Let us define two indicator
variables, denoted by d1i and d2i, where dki = 1 if tki is an observed lifetime and dki = 0
if tki is a censored observation, k = 1, 2 and i = 1, ..., n. In this way, if a sample of size
n is sampled from a population of interest, the likelihood function is given by
L(p) =
n∏
i=1
[P (T1i = t1i, T2i = t2i)]
d1id2i [P (T1i = t1i, T2i > t2i)]
d1i(1−d2i)
× [P (T1i > t1i, T2i = t2i)](1−d1i)d2i [S(t1i, t2i)](1−d1i)(1−d2i) ,
where p = (p1, p2, p3)
′ is the vector of parameters. Let us consider that the sample
is partioned into three subsets, where I0 : {i|t1i = t2i = ti}, I1 : {i|t1i < t2i} and I2 :
{i|t1i > t2i}. The likelihood function can be thus written by
L(p) =
∏
i∈I0
L0(p,wi)
∏
i∈I1
L1(p,wi)
∏
i∈I2
L2(p,wi), (4)
where wi = (t1i, d1i, t2i, d2i)
′ and the components L0(p,wi), L1(p,wi) and L2(p,wi) are
respectively given by
L0(p,wi) = p
ti−d1i
1 p
ti−d2i
2 p
ti−d1id2i
3 (1− p1)d1i(1−d2i) (1− p2)(1−d1i)d2i
× (1− p1p3 − p2p3 + p1p2p3)d1id2i ,
L1(p,wi) = p
t1i−d1i
1 (1− p1)d1i (p2p3)t2i−d2i (1− p2p3)d2i
and
L2(p,wi) = p
t2i−d2i
2 (1− p2)d2i (p1p3)t1i−d1i (1− p1p3)d1i .
From (4), the log-likelihood function is given by
lnL(p) =
∑
i∈I0
lnL0(p,wi) +
∑
i∈I1
lnL1(p,wi) +
∑
i∈I2
lnL2(p,wi).
Based on this expression, maximum likelihood and Bayesian estimators of the param-
eters p1, p2 and p3 were developed and compared by Achcar et al. (2016).
2.3. The cure fraction model
The survival function of the standard mixture cure fraction model has the form
SC(t) = θ + (1− θ)S(t) = 1− (1− θ)F (t), (5)
where θ is a parameter which represents the proportion of “long-term survivors” or
“cured” individuals, regarding the event of interest (0 < θ < 1), S(t) is the baseline
survival function for the susceptible or “non-cured” individuals and F (t) = 1 − S(t) is
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the respective cumulative distribution function (Boag, 1949). A generalization of (5)
considering bivariate lifetimes T1 and T2 is given by
SC(t1, t2) = PC(T1 > t1, T2 > t2)
= φ00 + φ11S12(t1, t2) + φ10S1(t1) + φ01S2(t2) (6)
where S12(t1, t2) is the joint survival function for the susceptible individuals to both
events, Sk(tk) is the baseline marginal survival function for Tk, k = 1, 2, and φ00, φ11,
φ10 and φ01 are parameters to be estimated. Let V1and V2 be two indicator variables
such that Vk = 1 for a susceptible individual in the lifetime Tk and Vk = 0 for a immune
individual in Tk, k = 1, 2. Thus, P (Vk = 0) = θk and P (Vk = 1) = 1− θk. Let ω be the
covariance between V1 and V2. Thus,
φ00 = P (V1 = 0, V2 = 0) = P (V1 = 0)P (V2 = 0) + ω = θ1θ2 + ω,
φ10 = P (V1 = 1, V2 = 0) = P (V1 = 1)P (V2 = 0)− ω = (1− θ1)θ2 − ω,
φ01 = P (V1 = 0, V2 = 1) = P (V1 = 0)P (V2 = 1)− ω = θ1(1− θ2)− ω
and
φ11 = P (V1 = 1, V2 = 1) = P (V1 = 1)P (V2 = 1) + ω = (1− θ1)(1− θ2) + ω.
Note that φ00+φ11+φ10+φ01 = 1. In addition, θ1 = φ00+φ01 and θ2 = φ00+φ10 are
interpreted as the cure fractions related to the lifetimes T1 and T2, respectively. Let us
consider that each ith set of observations (t1i, d1i, t2i, d2i), i = 1, ..., n, can be classified
into one of four groups:
(a) C1: both t1i and t2i are complete observations, or say, they are uncensored lifetimes;
(b) C2: t1i is a complete observation and t2i is a censored lifetime;
(c) C3: t1i is a censored lifetime and t2i is a complete observation;
(d) C4: both t1i and t2i are censored lifetimes.
Therefore, the likelihood function in presence of cure function and right censoring is
given by
L(p,θ1, θ2, ω) =
∏
i∈C1
P1(t1i, t2i)
∏
i∈C2
P2(t1i, t2i)
∏
i∈C3
P3(t1i, t2i)
∏
i∈C4
P4(t1i, t2i), (7)
where p = (p1, p2, p3)
′,
P1(t1i, t2i) = φ11P (T1i = t1i, T2i = t2i), i ∈ C1,
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P2(t1i, t2i) = φ10P (T1i = t1i) + φ11P (T1i = t1i, T2i > t2i), i ∈ C2,
P3(t1i, t2i) = φ01P (T2i = t2i) + φ11P (T1 > t1, T2 = t2), i ∈ C3,
and, from (6),
P4(t1i, t2i) = SC(t1i, t2i), i ∈ C4.
Considering the BDBG distribution, we have
P1(t1i, t2i) =

φ11p
t1i−1
1 (1− p1) (p2p3)t2i−1 (1− p2p3) for T1i < T2i
φ11p
t2i−1
2 (1− p2) (p1p3)t1i−1 (1− p1p3) for T1i > T2i
φ11 (p1p2p3)
t1i−1 (1− p1p3 − p2p3 + p1p2p3) for T1i = T2i
,
P2(t1i, t2i) =
{
φ10P (T1i = t1i) + φ11p
t1i−1
1 (1− p1) (p2p3)t2i for T1i ≤ T2i
φ10P (T1i = t1i) + φ11p
t2i
2 (p1p3)
t1i−1 (1− p1p3) for T1i > T2i
,
P3(t1i, t2i) =
{
φ01P (T2i = t2i) + φ11p
t1i
1 (p2p3)
t2i−1 (1− p2p3) for T1i < T2i
φ01P (T2i = t2i) + φ11p
t2i−1
2 (1− p2) (p1p3)t1i for T1i ≥ T2i
,
where, from (1), P (Tki = tki) = (1− pkp3) (pkp3)tki−1 , k = 1, 2, and
P4(t1i, t2i) = φ00 + φ11P (T1i > t1i, T2i > t2i) + φ10S1(t1i) + φ01S2(t2i)
= φ00 + φ11p
t1i
1 p
t2i
2 p
max(t1i,t2i)
3 + φ10S1(t1i) + φ01S2(t2i).
From (3), we have that
P4(t1i, t2i) = φ00 + φ11p
t1i
1 p
t2i
2 p
max(t1i,t2i)
3 + φ10 (p1p3)
t1i−1 + φ01 (p2p3)t2i−1 .
Maximum-likelihood estimates for the parameters of interest are given by deriving the
logarithm of the likelihood function L(p,θ1, θ2) with respect to each parameter and by
equalizing the obtained expressions to zero. Considering that the resulting equations
does not have an explicit solution, the estimates of p1, p2, p3, θ1 and θ2 could be found
using numerical methods.
The Akaike information criterion (AIC), given by AIC = 2k − 2 lnL(β̂), where k
is the number of parameters in β̂ included in the model and lnL(β̂) is the maximum
value of the log-likelihood function, is used to compare fits of the model under different
formulations. The model with the lowest values of AIC is selected as fitting the sample
data better.
In this article, MLE for the parameters p1, p2, p3, θ1, θ2 and ω were computed using
the “maxLik” package of the R software (Henningsen and Toomet, 2011).
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2.4. Estimating the mean lifetime
In applications of the model to real data, estimates of the mean lifetime with the re-
spective precision can be very useful to the researcher. In the frequentist case, let us
consider the application of the “delta method” in estimating the sampling variances of
the mean of the lifetime Tk, k = 1, 2, considering only the susceptible individuals. From
(2),
g(pk, p3) =
1
1− pkp3 , k = 1, 2,
and an approximation of the variance of g(pk, p3) is obtained by
V ar [g(pk, p3)] ≈
[
∂
∂pk
g(pk, p3)
∂
∂p3
g(pk, p3)
]
Σ(pk,p3)
[
∂
∂pk
g(pk, p3)
∂
∂p3
g(pk, p3)
]
,
where
∂
∂pk
g(pk, p3) =
p3
(pkp3 − 1)2
,
∂
∂p3
g(pk, p3) =
pk
(pkp3 − 1)2
and Σ(pk,p3) is the respective maximum-likelihood estimated variance-covariance matrix.
Therefore, the Wald-type asymptotic 95% confidence limits for E (Tk) are given by
g(p̂k, p̂3)− 1.96
√
V ar [g(p̂k, p̂3)] , g(p̂k, p̂3) + 1.96
√
V ar [g(p̂k, p̂3)],
where g(p̂k, p̂3) is the point maximum likelihood estimate of the mean lifetime and p̂k
and p̂3 are the MLE for the parameters pk and p3, respectively, for k = 1, 2. An
estimate of the variance-covariance matrix Σ(pk,p3) is obtained as the inverse of the
Fisher information matrix, that is, the matrix of the expected second derivatives of the
log-likelihood function.
2.5. Bayesian analysis
According to Bayes’ theorem, the posterior knowledge about the parameters of interest is
proportional to the product of the respective prior knowledge and the likelihood function.
Thus, let us suppose that the parameters p1, p2, p3, θ1 and θ2 follow independent beta
distributions. In this case,
pj ∼ Beta (aj , bj) , j = 1, 2, 3,
and
θk ∼ Beta (ck, dk) , k = 1, 2,
where a1 > 0, a2 > 0, a3 > 0, b1 > 0, b2 > 0, b3 > 0, c1 > 0, c2 > 0, d1 > 0 and d2 > 0
are known hyperparameters. In addition, considering that 0 ≤ ω ≤ min(p1, p2)− p1p2,
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we can assume a generalized beta (GB) prior distribution for the covariance parameter
ω. The GB distribution is a continuous probability distribution ranged in an interval
not necessary equals to [0, 1]. The joint posterior density function for p1, p2, p3, θ1, θ2
and ω is written as
f (p,θ1, θ2, ω|w) ∝ L(p,θ1, θ2, ω)× f(p,θ1, θ2, ω),
where the likelihood function L(p,θ1, θ2, ω) is given by (7), f(p,θ1, θ2, ω) is given by
the product of the prior probability functions and w = (t1, d1, t2, d2)
′ is the vector
of observed variables. Expressions for the full conditional posterior distributions are
obtained by deriving the posterior distribution of each parameter given the data and all
other parameters included in the model. In this article, we use Markov Chain Monte
Carlo (MCMC) algorithms to get the posterior summaries of interest. In this way, we
generated 510,000 Gibbs samples for each parameter, where the first 10,000 simulated
samples were discarded as a burn-in period, which is used to minimize the effect of
the initial values. The Bayesian estimates for the parameters of interest are obtained
using the means of the respective posterior distributions. In addition, the 95% credible
interval for a given parameter is estimated from the 2.5th and 97.5th centiles of its
posterior distribution.
The deviance information criterion (DIC) is a generalization of the AIC for Bayesian
analysis, easily obtained from the samples generated by MCMC simulation (Spiegelhalter
et al., 2014). The DIC value is computed as DIC = D(β̂) + 2np = 2D −D(β̂), where
D(β̂) is the deviance evaluated using the mean of the parameters obtained from the
MCMC samples, D is the posterior mean of the deviance and np = D − D(β̂) is a
measure of model complexity given by the effective number of parameters of the model.
The model with the lowest values of DIC provides the best fit to data. Alternatively,
comparison between different models can be also assessed using the log pseudo marginal
likelihood (LPML) measure, derived from the conditional predictive ordinate (CPO)
statistics. The larger is the value of LPML, the better is the fit of the model (Geisser
and Eddy, 1979).
All Bayesian parameter estimates and their respective 95% credible intervals (95%CrI)
were obtained using the OpenBUGS software version 3.2.2. Convergence of the simulated
samples was verified by traceplots. Details of our OpenBUGS program code are provided
in an Appendix at the end of the paper.
3. Results
In this section, we present a numerical illustration of the proposed model to real medical
data from two previously published studies.
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3.1. The cervical carcinoma study
Let us consider the data from a study that included a total of 148 women diagnosed and
treated for invasive cervical carcinoma between 1992 and 2002 (Brenna et al., 2004).
This dataset was also used by Martinez and Achcar (2014) to illustrate the performance
of a bivariate model based on the generalized Lindley distribution and copula functions.
For the purposes of the present study, it was considered a subsample of 118 women
who received the standard treatment recommended by the International Federation of
Gynecology and Obstetrics (FIGO). Let us define the disease-free survival (DFS) as the
time from the date of surgery to the first event of disease recurrence and the overall
survival (OS) as the time from the date of surgery to the death. Thus, T1 and T2 are
random variables denoting the DFS and the OS times, respectively. Note that, in this
example, it is not possible the case in which T1 > T2, given that T2 is the time to death.
However, there are six observations in which T1 = T2. Both lifetimes are expressed in
complete months.
In Table 1, we have the Bayesian (posterior summaries) and maximum likelihood esti-
mates of the parameters for the model based on the BDBG distribution in the presence
of censored data and a cure fraction. Note that the Bayesian and maximum likelihood
estimates are very similar. Attempting to consider non-informative prior distributions
for the parameters, in the Bayesian analysis we assumed uniform U(0, 1) prior distri-
bution for the parameters p1, p2, p3, θ1 and θ2 (remember that the uniform U(0, 1) dis-
tribution is an especial case of the beta distribution with both hyperparameters set to
1). In addition, we also assume a generalized beta prior distribution for ω, given by
Beta(1, 1) × min(p1, p2) − p1p2. In a brief sensitivity analysis, we also assumed beta
prior distributions with both hyperparameters set to the value 0.5 for the parameters,
as a special case, but the results did not change substantially. In the frequentist case,
standard errors are given Table 1 for the parameters φ00, φ01, φ10 and φ11, and also for
the quantities E(T1) and E(T2), which were obtained using the “delta method”. We can
note that the Wald method produced unrealistic confidence intervals (CI) for p3, φ01
and φ10, given that the upper limits can be higher than 1 and the lower limits can be
lower than 0.
We also fitted alternative models assuming independence between the probabilities V1
and V2, which leads to ω = 0. In this case, the Bayesian model generated a DIC value
equals to 1189.0 and a LPML value equals to −595.41, suggesting that the model that
includes the term ω best fits the data, as indicated by the lowest DIC value and highest
LPML value (Table 1). In addition, the log-likelihood value under the frequentist model
that considers ω = 0 is −592.11 and the respective AIC value is 1194.21, which reinforces
this conclusion.
Figure 1 shows plots of the survival function considering the DFS (panel A) and
the OS times (panel B). This figure compares the survival functions obtained by the
Kaplan-Meier (KM) estimator and the Bayesian parametric model based on the BDBG
distribution in the presence of censored data and a cure fraction. The grey region in the
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Figure 1: Plots of the survival functions estimated by the Kaplan-Meier method and as-
suming the Bayesian bivariate model based on the BDBG distribution. Cen-
soring points are marked by vertical lines on the Kaplan-Meier survival curves.
The grey region in the plots describes 95% credible regions for the parametric
marginal survival functions. Data from the cervical carcinoma study (Brenna
et al., 2004)
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Table 1: Bayesian and maximum likelihood estimates. Data from the cervical carcinoma
study (Brenna et al., 2004).
Bayesian estimates Maximum likelihood estimates
Parameter mean
standard
deviation
95%CrI estimate
standard
error
Wald-type 95%CI
p1 0.9395 0.0078 (0.9232 , 0.9539) 0.9399 0.0077 (0.9249 , 0.9551)
p2 0.9838 0.0097 (0.9652 , 0.9992) 0.9735 0.0043 (0.9651 , 0.9819)
p3 0.9836 0.0098 (0.9652 , 0.9991) 0.9979 0.0033 (0.9914 , 1.0043)
φ00 0.5659 0.0509 (0.4662 , 0.6650) 0.5652 0.0724
(a) (0.4232 , 0.7071)
φ01 0.0273 0.0205 (0.0012 , 0.0778) 0.0281 0.0753
(a) (-0.1196 , 0.1758)
φ10 0.0112 0.0113 (0.0002 , 0.0420) 0.0128 0.0698
(a) (-0.1240 , 0.1495)
φ11 0.3957 0.0490 (0.3004 , 0.4925) 0.3940 0.0899
(a) (0.2176 , 0.5703)
ω 0.2214 0.0137 (0.1899 , 0.2431) 0.2223 0.0497 (0.1249 , 0.3197)
θ1 0.4069 0.0491 (0.3107 , 0.5031) 0.4067 0.0698 (0.2698 , 0.5435)
θ2 0.4230 0.0511 (0.3249 , 0.5231) 0.4221 0.0929 (0.2398 , 0.6043)
E(T1) 13.49 2.204 (10.05 , 18.47) 16.13 1.686
(a) (12.82 , 19.43)
E(T2) 31.42 4.712 (23.44 , 41.84) 35.05 4.208
(a) (26.80 , 43.29)
LPML : −549.54, DIC : 1099.0 Log-likelihood : −547.90, AIC: 1107.807
(a)Standard errors obtained using the \ delta method”.
Note: 95%CrI, 95% credible interval; 95%CI, 95% confidence interval.
plots describes 95% credible regions for the marginal survival functions, obtained from
the 2.5th and 97.5th centiles of the posterior distribution for SC(t) (see equation (5))
at a lifetime t = t∗, where t∗ ≥ 1 is an integer value. The plots in Figure 1 suggest a
reasonable approximation between the KM estimates and the values predicted by the
parametric model.
3.2. The diabetic retinopathy study
In this subsection we consider the model based on the BDBG distribution in the presence
of censoring and a cure fraction for the data from the Diabetic Retinopathy Study
(Huster et al., 1989), where the objective was to assess the efficacy of photocoagulation
treatment for proliferativeretinopathy. Each patient had one eye randomized to laser
treatment and the other eye received no treatment. The main endpoint of this study
was the severe visual loss in each eye. Let T1 and T2 be two random variables denoting the
time up to visual loss for the control eye and the time up to visual loss for the treatment
eye, respectively. Censoring was caused by death, dropout or end of the study. Table 2
compares the results obtained from the Bayesian analysis and the maximum likelihood
estimation. In the Bayesian analysis, the choice of the prior distributions was similar to
that of the previous application. As can be seen, the Bayesian and maximum likelihood
estimates are very close to each other. We note that the upper limit of the 95%CI for p3
is higher than 1, and the lower limit of the 95%CI for φ01 is lower than 0, reinforcing that
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Table 2: Bayesian and maximum likelihood estimates. Data from the diabetic retinopa-
thy study (Huster et al., 1989).
Bayesian estimates Maximum likelihood estimates
Parameter mean
standard
deviation
95%CrI estimate
standard
error
Wald-type 95%CI
p1 0.9720 0.0083 (0.9548 , 0.9872) 0.9711 0.0084 (0.9546 , 0.9875)
p2 0.9713 0.0057 (0.9594 , 0.9815) 0.9703 0.0059 (0.9586 , 0.9820)
p3 0.9937 0.0029 (0.9871 , 0.9982) 0.9952 0.0026 (0.9902 , 1.0003)
φ00 0.3119 0.0620 (0.2162 , 0.4618) 0.2981 0.0516
(a) (0.1968 , 0.3992)
φ01 0.0594 0.0319 (0.0069 , 0.1289) 0.0559 0.0360
(a) (-0.0147 , 0.1265)
φ10 0.3472 0.0672 (0.2070 , 0.4755) 0.3493 0.0551
(a) (0.2413 , 0.4573)
φ11 0.2815 0.0519 (0.1727 , 0.3765) 0.2967 0.0493
(a) (0.2001 , 0.3933)
ω 0.0667 0.0239 (0.0212 , 0.1156) 0.0689 0.0236 (0.0226 , 0.1152)
θ1 0.6286 0.0669 (0.4626, 0.7288) 0.6461 0.0540 (0.5401 , 0.7520)
θ2 0.3409 0.0616 (0.2115 , 0.4503) 0.3529 0.0613 (0.2323 , 0.4728)
E(T1) 31.76 10.170 (19.19 , 57.49) 29.82 7.952
(a) (14.23 , 45.41)
E(T2) 29.68 5.488 (21.08 , 42.28) 29.14 5.596
(a) (18.17 , 40.11)
LPML : −824.74, DIC : 1649.0 Log-likelihood : −819.64, AIC: 1651.28
(a)Standard errors obtained from the Delta method.
Note: 95%CrI, 95% credible interval; 95%CI, 95% confidence interval.
the Wald-type confidence intervals can produce unrealistic results when the respective
parameter is estimated to be close to 0 or 1.
If we assume independence between the probabilities V1 and V2, a model fitted using
ω = 0 has a DIC value of 1655.0, and a LPML of −828.14, as opposed to respective
values of 1649.0 and −824.74 from the results in Table 2.
In the plots in Figure 2 we compared the survival functions for the T1 and T2 lifetimes
estimated by the KM method and the marginal survival functions obtained from the
Bayesian parametric model based on the BDBG distribution. We can note that the
estimated survival functions are very close to each other. As in the previous application
example, the grey region in the plots describes 95% credible regions for the parametric
marginal survival functions.
4. Discussion and remarks
In this paper, we extend the problem of parameter estimation for the model based on
the BDBG distribution in presence of censoring, as discussed by Achcar et al. (2016), to
the case where a cure fraction is present. We showed that the frequentist and Bayesian
approaches can be used for the purpose of estimating the parameters of the model, and
Electronic Journal of Applied Statistical Analysis 667
0 20 40 60 80
0.0
0.2
0.4
0.6
0.8
1.0
A. Control eye
T1 (months)
Su
rv
iva
l f
un
ct
io
n,
 S
c(t
)
l
l
l
l
l
l
l
lllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll
l
Kaplan−Meier estimates
B−D parametric estimates
0 20 40 60 80
0.0
0.2
0.4
0.6
0.8
1.0
B. Treatment eye
T2 (months)
Su
rv
iva
l f
un
ct
io
n,
 S
c(t
)
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
lllllllllllllllllllllllllllllllllllllllllllllllllllllllllll
l
Kaplan−Meier estimates
B−D parametric estimates
Figure 2: Plots of the survival functions estimated by the Kaplan-Meier method and as-
suming the Bayesian bivariate model based on the BDBG distribution. Cen-
soring points are marked by vertical lines on the Kaplan-Meier survival curves.
The grey region in the plots describes 95% credible regions for the parametric
marginal survival functions. Data from the diabetic retinopathy study (Huster
et al., 1989).
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the use of free available software like the popular R and OpenBUGS software provide a
great facility for this task.
For the Bayesian analysis of bivariate models with cure fractions, a number of authors
assume a Dirichlet prior for the parameters φ00, φ11, φ10 and φ01, since φ00 + φ11 +
φ10 + φ01 = 1 (for examples, see Achcar et al. (2013) or Davarzani et al. (2015)). In the
present article, we alternatively assumed prior beta distributions for the parameters θ1
and θ2, such that θ1 = φ00 + φ01 and θ2 = φ00 + φ10 are the cure fractions related to
the lifetimes T1 and T2, respectively. As an advantage of this choice, we observed that
assuming dependence between the random variables V1 and V2 by the introduction of
the parameter ω denoting the covariance between these indicator variables resulted in
much better fit of the proposed model for the numerical examples.
Achcar et al. (2016) state that models based on bivariate discrete distributions could
be good alternatives to the analysis of bivariate real data in presence of censoring, since
we usually find computational difficulties to get inferences for the parameters of inter-
est using standard continuous lifetime distributions as the popular Block and Basu or
the Marshall and Olkin bivariate exponential distributions. In this way, the paramet-
ric models based on the BDBG distribution are a good alternative to analyse bivariate
discrete lifetime data, considering the ease of implementation using computational soft-
ware as R or OpenBUGS. However, an important limitation of the BDBG distribution
is that their marginal hazard functions are constant, and this can be unrealistic in many
applications. Thus, future studies will be required to extend the BDBG distribution
to provide a model with a more flexible hazard function while maintaining the ease of
computational implementation.
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Appendix
A. OpenBUGS
The OpenBUGS code used for estimating the parameters of the BDBG distribution with
presence of censoring and a cure fraction is given below.
model {
for (i in 1:N) {
difT[i] <- t1[i] - t2[i]
k1[i] <- 1 - step(difT[i])
k3[i] <- equals(t1[i],t2[i])
k2[i] <- (1-k1[i])*(1-k3[i])
PT1[i] <- (1-p[1]*p[3])*pow(p[1]*p[3],t1[i]-1)
PT2[i] <- (1-p[2]*p[3])*pow(p[2]*p[3],t2[i]-1)
P1A[i] <- phi[1]*pow(p[1],t1[i]-1)*(1-p[1])
*pow(p[2]*p[3],t2[i]-1)*(1-p[2]*p[3])
P1B[i] <- phi[1]*pow(p[2],t2[i]-1)*(1-p[2])
*pow(p[1]*p[3],t1[i]-1)*(1-p[1]*p[3])
P1C[i] <- phi[1]*pow(p[1]*p[2]*p[3],t1[i]-1)
*(1-p[1]*p[3]-p[2]*p[3]+p[1]*p[2]*p[3])
P2A[i] <- phi[2]*PT1[i]+phi[1]*pow(p[1],t1[i]-1)
*(1-p[1])*pow(p[2]*p[3],t2[i])
P2B[i] <- phi[2]*PT1[i]+phi[1]*pow(p[2],t2[i])
*pow(p[1]*p[3],t1[i]-1)*(1-p[1]*p[3])
P2C[i] <- P2A[i]
P3A[i] <- phi[3]*PT2[i]+phi[1]*pow(p[1],t1[i])
*pow(p[2]*p[3],t2[i]-1)*(1-p[2]*p[3])
P3B[i] <- phi[3]*PT2[i]+phi[1]*pow(p[2],t2[i]-1)
*(1-p[2])*pow(p[1]*p[3],t1[i])
P3C[i] <- P3B[i]
P4[i] <- phi[4]+phi[1]*pow(p[1],t1[i])*pow(p[2],t2[i])
*pow(p[3],max(t1[i],t2[i]))
+phi[2]*pow(p[1]*p[3],t1[i]-1)
+phi[3]*pow(p[2]*p[3],t2[i]-1)
P1[i] <- pow(P1A[i],k1[i])*pow(P1B[i],k2[i])*pow(P1C[i],k3[i])
P2[i] <- pow(P2A[i],k1[i])*pow(P2B[i],k2[i])*pow(P2C[i],k3[i])
P3[i] <- pow(P3A[i],k1[i])*pow(P3B[i],k2[i])*pow(P3C[i],k3[i])
L[i] <- pow(P1[i],d1[i]*d2[i])*pow(P2[i],d1[i]*(1-d2[i]))
*pow(P3[i],(1-d1[i])*d2[i])*pow(P4[i],(1-d1[i])*(1-d2[i]))
logL[i] <- log(L[i])
zeros[i] <- 0
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zeros[i] ~ dloglik(logL[i])
}
phi[1] <- (1-theta[1])*(1-theta[2]) + w
phi[2] <- (1-theta[1])*theta[2] - w
phi[3] <- theta[1]*(1-theta[2]) - w
phi[4] <- theta[1]*theta[2] + w
# Prior distributions
theta[1] ~ dbeta(1,1)
theta[2] ~ dbeta(1,1)
p[1] ~ dbeta(1,1)
p[2] ~ dbeta(1,1)
p[3] ~ dbeta(1,1)
w <- g*(min(theta[1],theta[2]) - theta[1]*theta[2])
g ~ dunif(0,1)
# Means of the lifetimes
m[1] <- 1/(1-p[1]*p[3])
m[2] <- 1/(1-p[2]*p[3])
# Marginal survival functions
for (t in 1:120) {
S1[t] <- theta[1]+(1-theta[1])*pow(p[1]*p[3],t-1)
S2[t] <- theta[2]+(1-theta[2])*pow(p[2]*p[3],t-1) }
}
The data from the cervical carcinoma study in OpenBUGS format are shown below.
This dataset can be freely used by students and researchers on their own works, but the
article from (Brenna et al., 2004) should be cited as its source.
list(N=118, t1=c(28, 8, 116, 2, 1, 112, 7, 17, 32, 1, 19, 5, 29,
42, 91, 8, 91, 85, 2, 1, 89, 3, 1, 5, 1, 84, 1, 112, 99, 1, 6,
2, 62, 6, 103, 24, 1, 4, 19, 24, 26, 1, 8, 2, 2, 1, 77, 27, 65,
2, 64, 8, 16, 91, 54, 90, 60, 8, 1, 1, 93, 3, 101, 10, 5, 12, 1,
85, 37, 5, 89, 2, 91, 88, 44, 19, 1, 15, 69, 88, 25, 36, 86, 45,
7, 22, 90, 2, 49, 9, 8, 66, 6, 15, 11, 1, 46, 23, 5, 28, 4, 4,
15, 13, 1, 1, 6, 32, 49, 23, 2, 39, 19, 37, 55, 43, 1, 1),
t2=c(30, 14, 120, 18, 8, 115, 16, 20, 40, 7, 29, 13, 94, 46, 99,
13, 92, 94, 10, 6, 90, 17, 6, 18, 4, 86, 10, 113, 100, 10, 14, 13,
69, 13, 108, 52, 7, 5, 23, 52, 33, 4, 103, 17, 6, 6, 80, 31, 68,
102, 64, 19, 25, 96, 56, 95, 65, 55, 6, 18, 94, 9, 102, 13, 31,
18, 11, 90, 45, 14, 90, 16, 91, 92, 48, 25, 2, 27, 69, 89, 56,
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43, 88, 45, 13, 26, 93, 8, 92, 14, 12, 71, 9, 24, 15, 8, 49, 29,
9, 32, 9, 7, 20, 19, 5, 5, 12, 38, 53, 29, 6, 44, 22, 42, 55, 43,
5, 5),
d1=c(0, 1, 0, 1, 0, 0, 1, 1, 1, 0, 1, 1, 1, 1, 1, 1, 1, 0, 1, 1, 0,
1, 1, 1, 0, 0, 1, 0, 0, 1, 1, 1, 1, 1, 0, 1, 1, 0, 0, 1, 1, 0, 1,
1, 1, 1, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 1, 1,
1, 1, 0, 1, 1, 0, 1, 0, 0, 1, 1, 0, 1, 0, 0, 1, 1, 0, 0, 1, 1, 0,
1, 1, 1, 1, 0, 1, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0,
0, 0, 0, 0, 0, 0, 0, 0, 1),
d2=c(0, 1, 0, 1, 0, 0, 1, 1, 1, 0, 1, 1, 0, 1, 1, 1, 1, 0, 1, 1, 0,
1, 1, 1, 0, 0, 1, 0, 0, 1, 1, 1, 1, 1, 0, 1, 1, 0, 0, 1, 1, 0, 0,
1, 1, 1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 1, 1,
1, 1, 0, 1, 1, 0, 1, 0, 0, 1, 1, 0, 1, 0, 0, 1, 1, 0, 0, 1, 1, 0,
1, 1, 1, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,
0, 0, 0, 0, 0, 0, 0, 0, 0))
